We serve Chemical Name:1-pentenylboronic acid CAS:104376-24-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-pentenylboronic acid
CAS.NO:104376-24-1
Synonyms:RARECHEM AH PB 0245;1-Pentenylboronic acid;MFCD01074677;E-PENTEN-1-YLBORONIC ACID;trans-1-pentenylboronic acid
Molecular Formula:C5H11BO2
Molecular Weight:113.95100
HS Code:2931900090
Physical and Chemical Properties:
Melting point:100-105ºC(lit.)
Boiling point:209.9ºC at 760mmHg
Density:0.936g/cm3
Index of Refraction:1.435
PSA:40.46000
Exact Mass:114.08500
LogP:0.35470
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like RARECHEM AH PB 0245 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-1-pentenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,E-PENTEN-1-YLBORONIC ACID Use and application,E-PENTEN-1-YLBORONIC ACID technical grade,usp/ep/jp grade.
Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 1-pentenylboronic acid manufacturer You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 1-pentenylboronic acid supplier You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 1-pentenylboronic acid vendor The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. 1-pentenylboronic acid factory Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).
